Collectively, these findings demonstrate that CREBZF is dynamically regulated in response to inflammatory stimuli, and hyper‐activation of CREBZF in macrophages contributes to systemic insulin resistance and type 2 diabetes. This evidence concerns the gene CREBZF and type 2 diabetes mellitus.